C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2004
12/16/2004	WO2004108765A2 Extracellular aspergillus polypeptides
12/16/2004	WO2004108762A1 Immobilized membrane proteins and methods of use therefor
12/16/2004	WO2004108761A2 Canine ghrh gene, polypeptides and methods of use
12/16/2004	WO2004108760A2 Improved secretion of neublastin
12/16/2004	WO2004108759A1 Hypoallergenic hevein for immunotherapy of latex allergy
12/16/2004	WO2004108758A1 Phl p 5a derivatives with reduced allergenicity and retained t-cell reactivity
12/16/2004	WO2004108757A2 Antimicrobial polypeptides
12/16/2004	WO2004108756A2 Sars coronavirus peptides and uses thereof
12/16/2004	WO2004108755A2 Chimeric adenovirus capsid proteins
12/16/2004	WO2004108754A2 Herpes simplex virus us11 protein and hipk2 protein complexes and uses thereof
12/16/2004	WO2004108753A1 Immunomodulating compositions, uses therefor and processes for their production
12/16/2004	WO2004108752A1 Antimicrobial polypeptides
12/16/2004	WO2004108751A1 A cardio myopeptidin, the production and the use thereof
12/16/2004	WO2004108750A1 Process for the separation of proteins
12/16/2004	WO2004108748A2 Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses
12/16/2004	WO2004108142A2 Inhibitors of tip-1 for treatment tissue damage
12/16/2004	WO2004108079A2 Parkin-interacting proteins
12/16/2004	WO2004108074A2 Vascular endothelial growth factor fusion constructs and uses thereof
12/16/2004	WO2004108071A2 Targeting polypeptides to the central nervous system
12/16/2004	WO2004107874A1 Method for the preparation of an amino acids-containing solution and use of such a solution
12/16/2004	WO2004096844A3 Group 1 mite polypeptide variants
12/16/2004	WO2004093532A3 Generation of plants with altered oil content
12/16/2004	WO2004090115A3 Renilla gfp mutants with increased fluorescent intensity and special shift
12/16/2004	WO2004089072A3 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene
12/16/2004	WO2004087766A3 Peptabody for cancer treatment
12/16/2004	WO2004087206A3 Methods of treating diabetes by blocking vegf-mediated activity
12/16/2004	WO2004078945A3 Nucleotide sequences of 2s albumin gene and its promoter from grape and uses thereof
12/16/2004	WO2004078905A8 Agents for phytoremediation
12/16/2004	WO2004075861A3 Recombinant adeno-associated virus production
12/16/2004	WO2004074430A3 Compositions, splice variants and methods relating to lung specific genes and proteins
12/16/2004	WO2004070035A3 Method for increasing efficiency of homologous recombination in plants
12/16/2004	WO2004065410A3 Mntf peptides and compositions and methods of use
12/16/2004	WO2004064500A3 Transcriptional coactivator asc-2
12/16/2004	WO2004061423A3 Compositions and methods for diagnosing and treating colon cancers
12/16/2004	WO2004048527A3 Cells resistant to chemotherapeutic compounds and uses thereof
12/16/2004	WO2004046336A3 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway
12/16/2004	WO2004044152A3 A novel pth responsive gene
12/16/2004	WO2004035731A3 Increasing host plant susceptibility to agrobacterium infection by overexpression of the arabidopsis vip1 gene
12/16/2004	WO2004033481A3 Igf-binding protein-derived peptide or small molecule
12/16/2004	WO2004029218A3 Receptors and membrane-associated proteins
12/16/2004	WO2004022697A3 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
12/16/2004	WO2004014940A3 PEPTIDES AS SOLUBILIZING EXCIPIENTS FOR TRANSFORMING GROWTH FACTOR ß PROTEINS
12/16/2004	WO2004006848A3 Combination therapies with ftc for the treatment of hepatitis b virus infection
12/16/2004	WO2004003156A3 Il-21 as a regulator of immunoglobin production
12/16/2004	WO2003104434A3 A method to amplify variable sequences without imposing primer sequences
12/16/2004	WO2003092582B1 Chimeric ebola virus envelopes and uses therefor
12/16/2004	WO2003090514A8 Adipocyte complement related protein zacrp14
12/16/2004	WO2003066666A3 Compositions and methods for treatment of vitamin d deficiency
12/16/2004	WO2003059268A3 A novel germ cell-specific contraceptive target
12/16/2004	WO2003057833A3 Mutant chromophores/fluorophores and methods for making and using the same
12/16/2004	WO2003054152A3 Novel nucleic acids and polypeptides
12/16/2004	WO2003050245A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/16/2004	WO2003027254A3 15625 receptor, a novel g-protein coupled receptor
12/16/2004	WO2003013425A9 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation
12/16/2004	WO2003005953A3 Viral proteins capable of binding lar
12/16/2004	WO2002099084A9 Composite binding polypeptides
12/16/2004	WO2002070665A8 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
12/16/2004	US20040255351 Protein associated with homologous recobination for use as gene insertion tool in generating transgenic plants; bioreactors and heterologous gene expression
12/16/2004	US20040255350 Flax seed specific promoters
12/16/2004	US20040255349 Plant flower type targeting mads box gene
12/16/2004	US20040255348 Nucleotide sequences coding viral promoter sequences for use in detection of viral infection in plants; regulatory elements for expression of heterologous genes in cells
12/16/2004	US20040255347 Using site specific recombination to insert heterologous nucleotide sequences into plants tissue; enhancing nutrient quality of plants; bioreactors
12/16/2004	US20040254365 administering a fusion polypeptide including a signal peptide and a part of an envelope protein of the flavivirus; or an expression vector containing a nucleic acid encoding the fusion polypeptide; vaccines
12/16/2004	US20040254364 Phage display of a biologically active Bacillus thuringiensis toxin
12/16/2004	US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease
12/16/2004	US20040254361 Gene encoding protein from merozoite of Babesia caballi, recombinant protein obtained with said gene and use thereof
12/16/2004	US20040254360 Molecular identification of staphylococcus-type bacteria
12/16/2004	US20040254354 Extracellular matrix-binding proteins from Staphylococcus aureus
12/16/2004	US20040254351 Hyperglycosylated polypeptides
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254349 Mycobacterial antigens expressed under low oxygen tension
12/16/2004	US20040254348 Opiate receptor therapeutic protein/peptides for use in pain relief and management
12/16/2004	US20040254346 Human survivin interacting protein 1 (sip-1)
12/16/2004	US20040254345 for increasing gastric motility
12/16/2004	US20040254342 Substrates and assays for beta-secretase
12/16/2004	US20040254341 Human aspartyl protease peptide for use in identifying modulators for treatment and prevention of neurodegenerative and nervous system disorders; enzyme inhibitors
12/16/2004	US20040254340 Expression vetor comprising cell surface glycoprotein for use in prevention and treatment of neurodegenerative disorders; memory enhancement and learning
12/16/2004	US20040254339 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours
12/16/2004	US20040254338 Melanin-concentrating hormone antagonists
12/16/2004	US20040254140 Method for selective inactivation of viral replication
12/16/2004	US20040254138 Vectors containing genomic Dna, Rna encoding replacement gene; bone disordwers; vision defects; antidepressants; anticancer agents
12/16/2004	US20040254134 Modulating heart cells; administering polynucleotide; adjust contraction
12/16/2004	US20040254132 Ovary-specific genes and proteins
12/16/2004	US20040254130 Chlamydia antigens and corresponding dna fragments and uses thereof
12/16/2004	US20040254119 Polypeptide conjugates with extended circulating half-lives
12/16/2004	US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation
12/16/2004	US20040254115 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator
12/16/2004	US20040254114 Genetic engineering
12/16/2004	US20040254113 Cell calcification supressing proteins, and genes of the proteins
12/16/2004	US20040254111 Regulator of apoptosis and cell proliferation
12/16/2004	US20040254110 Methods for diagnosing and treating Alzheimer's disease
12/16/2004	US20040254108 Preparation and application of anti-tumor bifunctional fusion proteins
12/16/2004	US20040254106 Modified factor ix
12/16/2004	US20040254105 recombinant vectors and recombinant host cells
12/16/2004	US20040254101 Colon specific gene and protein and cancer
12/16/2004	US20040254099 Compounds and methods for modulating beta-catenin mediated gene expression
12/16/2004	US20040253728 New method
12/16/2004	US20040253723 Modulation of growth hormone receptor expression and insulin-like growth factor expression
12/16/2004	US20040253720 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences
12/16/2004	US20040253717 Rice sucrose tranporter gene promoter

1 ... 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 ... 2916